FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35915811000001105: Terazosin 2mg tablets and Terazosin 1mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110967501000001115 Terazosin 2mg tablets and Terazosin 1mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110967601000001116 Terazosin 2mg tablets and Terazosin 1mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Terazosin 2mg tablets and Terazosin 1mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Route of administration not applicable true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets and Terazosin 1mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) combination product indicator Combination product true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets and Terazosin 1mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets and Terazosin 1mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Not applicable dose form indicator true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets and Terazosin 1mg tablets Is a Terazosin true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets and Terazosin 1mg tablets Is a Product containing terazosin false Inferred relationship Existential restriction modifier
Terazosin 2mg tablets and Terazosin 1mg tablets Has active ingredient Terazosin false Inferred relationship Existential restriction modifier
Terazosin 2mg tablets and Terazosin 1mg tablets Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets and Terazosin 1mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets and Terazosin 1mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Terazosin 2mg tablets and Terazosin 1mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Terazosin 2mg tablets and Terazosin 1mg tablets 28 tablet Has VMP True Terazosin 2mg tablets and Terazosin 1mg tablets Inferred relationship Existential restriction modifier
Hytrin tablets starter pack (Abbott Laboratories Ltd) Is a True Terazosin 2mg tablets and Terazosin 1mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start